EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer

Yashi Ruan, Lixia Guan, Yuting Wang, Yifei Geng, Xiaoran Wang, Miao-Miao Niu, Li Yang, Cen Xu, Zhen Xu

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s479113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yashi Ruan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Reproductive Medicine and Oncology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, P…. Hauptthemen laut MEDLINE: Histone Deacetylase 2, Ataxia Telangiectasia Mutated Proteins, Testicular Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 2Ataxia Telangiectasia Mutated ProteinsTesticular NeoplasmsAntineoplastic AgentsDrug Screening Assays, AntitumorCell ProliferationHistone Deacetylase InhibitorsMaleHumansAnimalsMiceStructure-Activity RelationshipDrug DiscoveryMolecular StructureMolecular Docking SimulationDose-Response Relationship, DrugMolecular Dynamics SimulationMice, NudeNeoplasms, ExperimentalCell Line, TumorMice, Inbred BALB C

Stichwörter der Autor:innen

ataxia telangiectasia mutateddual-targeting inhibitorshistone deacetylase 2structure-based virtual screeningtesticular germ cell tumors

Substanzen

Histone Deacetylase 2Ataxia Telangiectasia Mutated ProteinsHDAC2 protein, humanAntineoplastic AgentsHistone Deacetylase InhibitorsATM protein, human

Autor:innen und Institutionen

  • Department of Urology, Reproductive Medicine and Oncology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, People's Republic of China.
  • Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.

Zitieren

APA

Ruan, Y., Guan, L., Wang, Y., Geng, Y., Wang, X., Niu, M. M., Yang, L., Xu, C., & Xu, Z. (2024). Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s479113

Vancouver

Ruan Y, Guan L, Wang Y, Geng Y, Wang X, Niu MM, et al. Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s479113

BibTeX
@article{Ruan2024,
  author = {Ruan, Yashi and Guan, Lixia and Wang, Yuting and Geng, Yifei and Wang, Xiaoran and Niu, Miao-Miao and Yang, Li and Xu, Cen and Xu, Zhen},
  title = {Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s479113}
}
Kostenlos starten →